|[July 30, 2014]
BIOLASE Announces That Non-Executive Board Member Federico Pignatelli Has Withdrawn His Lawsuit against Company
IRVINE, Calif. --(Business Wire)--
BIOLASE, Inc. (BIOL), the world's leading dental laser manufacturer and
distributor, announced today that non-executive board member Federico
Pignatelli yesterday withdrew his lawsuit against the Company and four
other members of BIOLASE's board of directors.
Mr. Pignatelli filed the lawsuit on July 21, 2014 in Delaware Chancery
Court and had sought, among other things, expedited proceedings with
respect to his claims relating to his attempt to nominate candidates for
election to BIOLASE's board of directors, the Company's and certain
directors' alleged breach of an agreement to nominate Mr. Pignatelli as
a director candidate at the upcoming annual meeting, voting rights of
shares issued in the Company's July 22, 2014 "at market" private
placement and the Company's recently enacted bylaw amendments, including
the fee-shifting bylaw provision. The BIOLASE annual meeting remains
scheduled for August 27, 2014.
About BIOLASE, Inc.
BIOLASE, Inc. is a biomedical company that develops, manufactures, and
markets innovative lasers in dentistry and medicine and also markets and
distributes high-end 2D and 3D digital imaging
equipment, CAD/CAM intraoral scanners, and in-office milling
machines and 3D printers; products that are focused on technologies that
advance the practice of dentistry and medicine.
The Company's proprietary laser products incorporate approximately 300
patented and patent-pending technologies designed to provide
biologically clinically superior performance with less pain and faster
recovery times. Its innovative products provide cutting-edge technology
at competitive prices to deliver the best results for dentists and
patients. BIOLASE's principal products
are revolutionary dental laser systems that perform a broad range of
dental procedures, including cosmetic and complex surgical applications,
and a full line of dental imaging equipment. BIOLASE has sold more than
25,000 laser systems. Other laser products under development address
ophthalmology and other medical and consumer markets.
For updates and information on WaterLase and laser dentistry, find
BIOLASE online at www.biolase.com,
Facebook (News - Alert) at www.facebook.com/biolase,
Twitter at www.twitter.com/biolaseinc,
Pinterest at www.pinterest.com/biolase,
LinkedIn (News - Alert) at www.linkedin.com/company/biolase,
Google (News - Alert)+ at www.google.com/+BIOLASEIrvine,
Instagram at www.instagram.com/biolaseinc,
and YouTube (News - Alert) at www.youtube.com/biolasevideos.
BIOLASE® and WaterLase® are registered trademarks
of BIOLASE, Inc.
Important Additional Information
BIOLASE, Inc. ("BIOLASE"), its directors and its executive officers are
deemed to be participants in the solicitation of proxies from BIOLASE
stockholders in connection with BIOLASE's 2014 annual meeting of
stockholders. BIOLASE has filed a definitive proxy statement with the
U.S. Securities and Exchange Commission (the "SEC (News - Alert)") in connection with
such solicitation of proxies from BIOLASE stockholders. BIOLASE
STOCKHOLDERS ARE STRONGLY ENCOURAGED TO READ THE DEFINITIVE PROXY
STATEMENT AND ACCOMPANYING PROXY CARD AS THEY CONTAIN IMPORTANT
INFORMATION. Information regarding the identity of participants, and
their direct or indirect interests, by security holdings or otherwise,
is set forth in the definitive proxy statement filed with the SEC.
Stockholders are able to obtain the definitive proxy statement, any
amendments or supplements to the proxy statement and other documents
filed by BIOLASE with the SEC for no charge at the SEC's website at www.sec.gov.
Copies will also be available at no charge at BIOLASE's website at www.biolase.com
or by writing to BIOLASE at 4 Cromwell, Irvine, California 92618,
[ Back To Technology News's Homepage ]